Lord's Mark Industries Limited
Transaction Details
Lord's Mark Industries Limited executed definitive transaction documents and completed the acquisition of a 30% equity stake in Aivita Private Limited (CIN: U46497MH2026PTC470742) on July 3, 2026.
Target Company Information
Aivita Private Limited is a private limited company incorporated under the Companies Act, 2013 on April 23, 2026. The company is engaged in developing healthcare technology solutions with a focus on building India's execution and intelligence layer for robotic surgery.
Authorised Share Capital: ₹25,00,000
Paid-up Share Capital: ₹10,00,000
Since the company was recently incorporated, audited financial statements and turnover details for the last three financial years are not available.
Acquisition Terms
The company acquired 30,000 equity shares of ₹10 each in Aivita Private Limited for an aggregate cash consideration of ₹3,00,000 (Rupees Three Lakhs only).
Ownership and Control
This acquisition represents 30% of the paid-up equity share capital of Aivita Private Limited. Upon completion, Aivita is expected to become an Associate Company of Lord's Mark Industries Limited under the applicable provisions of the Companies Act, 2013 and Indian Accounting Standards.
Strategic Rationale
The acquisition is a strategic investment aligned with Lord's Mark's vision of strengthening its healthcare business. The investment will enable participation in the robotic surgery ecosystem by supporting:
- Deployment of robotic surgical platforms
- Strengthening surgeon training
- Improving utilization of advanced medical infrastructure
- Fostering technology-enabled collaboration among hospitals and clinicians
The acquisition complements the Company's expanding healthcare portfolio comprising diagnostics, medical devices, AI-enabled healthcare solutions, and indigenous manufacturing.
Regulatory Aspects
The acquisition does not fall within the ambit of a related party transaction. No governmental or regulatory approval was required for this acquisition, except such approvals as may be applicable in the ordinary course.
Management Commentary
Mr. Sachidanand Upadhyay, Managing Director of Lord's Mark Industries Limited, stated: "This is far more than a strategic investment; it is an investment in the future of Indian healthcare. By becoming a strategic shareholder in Aivita, we are reaffirming our commitment to building the medical infrastructure India needs for the next several decades. Our vision is to make advanced robotic surgery more accessible, strengthen clinical capabilities and contribute to an ecosystem where technology empowers better patient outcomes across the country."
Compliance Reference
This disclosure is made in compliance with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.